1
Investors
About
PharmaLundensis develops pharmaceuticals targeting chronic obstructive pulmonary disease, chronic bronchitis, and influenza-induced lung failure, and also creates systems to eliminate pharmaceutical drugs and multi-resistant bacteria from hospital wastewater.
Explore PharmaLundensis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.